Attributes | Values |
---|
rdf:type
| |
rdfs:seeAlso
| |
Description
| - This paper describes 20 newly prepared bispyridinium inhibitors of potential concern for Myasthenia gravis (MG). The newly prepared compounds were evaluated in vitro on human erythrocyte acetylcholinesterase (AChE) and human plasmatic butyrylcholinesterase (BChE). Their inhibitory ability was expressed as IC50 and compared to standard carbamate drugs. Three compounds presented promising inhibition (in µM range) of both enzymes in vitro similar to the used standards. The novel inhibitors did not present selectivity between AChE and BChE. Two newly prepared compounds were chosen for docking studies and confirmed apparent pí-pí or pí-cationic interactions aside enzyme's catalytic sites. The kinetics assay confirmed non-competitive inhibition of AChE by two best newly prepared compounds.
- This paper describes 20 newly prepared bispyridinium inhibitors of potential concern for Myasthenia gravis (MG). The newly prepared compounds were evaluated in vitro on human erythrocyte acetylcholinesterase (AChE) and human plasmatic butyrylcholinesterase (BChE). Their inhibitory ability was expressed as IC50 and compared to standard carbamate drugs. Three compounds presented promising inhibition (in µM range) of both enzymes in vitro similar to the used standards. The novel inhibitors did not present selectivity between AChE and BChE. Two newly prepared compounds were chosen for docking studies and confirmed apparent pí-pí or pí-cationic interactions aside enzyme's catalytic sites. The kinetics assay confirmed non-competitive inhibition of AChE by two best newly prepared compounds. (en)
|
Title
| - Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage - initial study for Myasthenia gravis implications
- Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage - initial study for Myasthenia gravis implications (en)
|
skos:prefLabel
| - Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage - initial study for Myasthenia gravis implications
- Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage - initial study for Myasthenia gravis implications (en)
|
skos:notation
| - RIV/60162694:G44__/10:00002231!RIV13-GA0-G44_____
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - I, P(GP203/09/P130), P(OVUOFVZ200805), S
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/60162694:G44__/10:00002231
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - docking; in vitro; quaternary; Myasthenia gravis; inhibitor; cholinesterase (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Bioorganic & Medicinal Chemistry Letters
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Doležal, Martin
- Dohnal, Vlastimil
- Hrabinová, Martina
- Jung, Young-Sik
- Kuča, Kamil
- Musílek, Kamil
- Pohanka, Miroslav
- Holas, Ondřej
- Komlóová, Markéta
- Nachon, Florian
- Závadová, Vlasta
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |
http://bibframe.org/vocab/doi
| - 10.1016/j.bmcl.2010.01.034
|
http://localhost/t...ganizacniJednotka
| |